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Hydroa vacciniforme-like lymphoma (HVL) is a rare type of Epstein-Barr virus (EBV)-positive lymphoma of cytotoxic
T-cell or natural killer cell origin that mainly affect children, characterized by a vesicopapular skin eruption that
clinically resemble hydroa vacciniforme (HV). In current study, we report an adult patient with the tumor. The
patient presented similar morphologic, immunophenotypic and genotypic changes of the disease with that
occurred in children, whereas clinically, he showed a prolonged clinical course without hepatosplenomegaly or
generalized lymphadenopathy. Whether there are some differences in biologic behavior between children and
adults still remains unknown and it is necessary to collect more data to observe and to investigate in the future.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/7644172219178472
Keywords: Hydroa vacciniforme-like lymphoma, Epstein-Barr virus, AdultHydroa vacciniforme-like lymphoma (HVLL) is a cutane-
ous cytotoxic T-cell or natural killer (NK) cell originated
lymphoma occurring in children and adolescents, but
not in adults, mainly reported from Asia, Central and
South America. In the updated WHO Classification of
tumor of Haematopoietic and lymphoid tissues (2008),
hydroa vacciniforme-like lymphoma has been recognized
as one of the Epstein-Barr virus (EBV)-positive lympho-
proliferative disorders of childhood [1]. In current study,
an adult patient with hydroa vacciniforme-like lymphoma
was reported with review of the literature.
Case history
A 19-year-old Asian male, complained of repeatedly hy-
perpyrexia for two years, multiple papules of the head for
more than one year, papules and blisters of the face and
trunk for eight months (Figure 1). Two years ago, the pa-
tient suffered from repeating fever, accompanying with
chilly, oral ulcer and night sweat as well. The examina-
tions for tuberculosis showed negative result. His
temperature came to normal level after anti-infection ther-
apy for about a week, but relapsed, also accompanying* Correspondence: liuweiping2001@vip.sina.com
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reproduction in any medium, provided the orwith cough and sputum. “Acute bronchitis caused by sal-
monella infection” was diagnosed, antibiotics and allo-
pathic treatment were given. The fever was down and the
patient was discharged from the hospital. Later on, the pa-
tient received anti-tuberculosis therapy for 9 months, in
which period his temperature is in the normal level. The
patient stopped anti-tuberculosis treatments and had a
fever again after three months. More than one year ago,
several needle point-sized papules appeared on his vertex,
and the patient was treated as “acne folliculitis”, but the
skin lesions increased and spread to the whole scalp. Eight
months ago, the patient complained of non-pitting edema
over his whole face, especially severe in the eyelids. There
was no abnormal urination or lower limb edema. Seven
months ago, several needle-point-to-millet-sized papules
appeared on the face, accompanying with a little itching
and blisters. The blisters were Nikolsky’s sign, filled with
clear yellow-colored fluid. Once the blisters were ruptured,
there leaved depressed cicatrix. The patient was treated
with Chinese homeopathic medicine (details unknown),
but the fever still kept occurring and the skin lesions
spread to the whole face, neck, trunk and both upper
limbs, with a pain in distal joints of both hands. Clinically,
hydroa vacciniforme-like lymphoma was suspected.
Laboratory examinations showed that red blood cell
(RBC) 4.28×109/L, white blood cell (WBC) 4.10×109/L,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Skin lesions of hydroa vacciniforme-like lymphoma on
the onset. Papulovascular eruptions on the head (A), facial skin
around nose (B) and thoracic skin (C).
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IU/L, CD3 subpopulation 83.20%. EBV-DNA level was
1.33E+04 copies/mL detected by real-time quantitative
Polymerase Chain Reaction (RT-qPCR). EBV-VCA-IgA
was positive, while EBV-EAD-IgG was negative. Type-B
ultrasonic examination showed portal vein thickening
and splenomegaly. Sputum culture found Pseudomonas
aeruginosa. Cervical lymph node biopsy was performed
and systemic EBV-positive T-cell lymphoproliferativedisease was diagnosed. Clinically, respiratory tract infec-
tion was also considered. The protocol of this study was
approved by the Institutional Review Board for ethical
committee of West China Hospital of Sichuan University,
and the study protocol adhered to guidelines by Helsinki
Convention.
Histopathology, immunophenotype, genotype, and EBV
status
Skin biopsy was performed. It featured an infiltration of a
variety of lymphocytes, plasma cells and neutrophils sur-
rounding the labial glands. No clear subepidermal blister
was found. In epidermis, a diffuse polymorphic lymphoid
infiltrate were found and the infiltrate pattern were mainly
perivascular and periadnexal. The infiltrates were promin-
ently composed of small-to-medium-sized atypical lym-
phocytes with moderate pale stained cytoplasm. The
nuclei were oval, round or irregular, with fine chromatin
and inconspicuous nucleoli. Mitotic figure was not easy to
be found (Figure 2A-C). Some of eosinophils intermingled.
Neither necrosis nor erythrophagocytosis was observed.
Immunophenotype analysis showed that these lympho-
cytes were positive for CD3ε (Figure 2D), CD2 (Figure 2E),
CD7, TIA-1, granzyme B and negative for CD4, CD8,
CD20, CD30, CD56, CD79a, CD117, S-100 and Langerin
with Ki-67 index being 40%~50%. EBER-positive cells
were detected according to in situ hybridization for
EBV-encoded small RNA (Figure 2F). On the basis of
morphology, immunohistochemical stain, and in situ
hybridization, as well as the clinical menifestations, the
diagnosis of hydroa vacciniforme-like lymphoma was
established.
Treatment and follow-up
The patient was treated with Haitangheji, a kind of Chinese
homeopathic medicine which is used for immuno-
suppression and anti-inflammation, ketotifen which is
most commonly used to treat IgE-mediated allergic dis-
eases, and other supportive treatments. α-interferon was
used to control the fever. Levofloxacin and sirolimus were
used to control fever, but the temperature still kept above
38°C; then prednisone was added. At last, the patient’s
temperature fell down to normal level and skin lesions
were also gradually disappeared and he was discharged
from the hospital. Three month later, the patient died, and
no more detail information about the disease was available.
Discussion
We reported an exceptional case of EBV-associated T/
NK-cell lymphoproliferative disorder in an adult who
shares similar characteristics of hydroa vacciniforme-like
lymphoma in the current WHO category.
EBV-positive T/NK-cell lymphomas recognized by the
WHO classification (2008) include extranodal NK/T-cell
Figure 2 Morphology changes, Immunohistochemical stain and in situ hybridization for EBV-encoded small RNA (EBER) of hydroa
vacciniforme-like lymphoma. A. The infiltrate is mainly concentrated in the epidermis and dermis, not subcutaneous areas. B-C. Neoplastic cells
are predominantly small without marked atypia. D. CD3ε positive. E. CD2 positive. F. EBER positive.
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temic EBV-positive T-cell lymphoproliferative disorder
of childhood, and hydroa vacciniforme-like T-cell lymph-
oma. All occur more frequently in Asians, and in the
Native Americans from Central and South America and
Mexico [2]. Except for hydroa vacciniforme-like lymph-
oma, all are aggressive diseases, with a final fatal out-
come in most cases.
Hydroa vacciniforme-like lymphoma (HVLL) has also
been called angiocentric cutaneous T-cell lymphoma of
childhood [3], and hydroa-like cutaneous T-cell lymph-
oma [4-6]. Most reports come from Asian area, inclu-
ding Japan, China and Korea [7]. Up to now, limited
researches about Hydroa vacciniforme-like lymphoma in
adult were reported in the literature due to its rarity.
HVLL is characterized by recurrent papulovesicles which
mainly presented in the sun-exposed area, and often ac-
companied by fever, lymadenopathy, hepatosplenomegaly
and increased liver enzyme, and the two year survival rate
is 36% [7]. In current report, the patient shares the similar
morphologic, immunophenotypic and genotypic changes
of HVLL in childhood reported in the literature, whereasclinically, he has a prolonged history (more than three
years), and only submendible lymphadenopathy was
detected with mild liver enzyme abnormality. Whether
there are some differences in biological behavior between
children and adult patients still needs necessary investiga-
tion in the future.
Hydroa vacciniforme-like lymphoma should be distin-
guished from a group of T-cell and NK cell lympho-
proliferative disorders presenting in the skin. The first is
Hydroa vacciniforme (HV). Typical HV is a self-limited
skin disease characterized by vesiculopapular eruptions
on the sun-exposed regions with vacciniforme scarring.
Systemic involvement is absent. Patients with HV-like
lymphoproliferative disorders may show some clinical
features mimicking typical HV at the onset of the disease
[8]. In addition, some cases of severe HV reported in
the literature before are actually included in Hydroa
vacciniforme-like lymphoma now [7]. The second diffe-
rential diagnosis is extranodal NK/T-cell lymphoma,
nasal type (ENKTCL-N). Unlike HVLL, cutaneous
ENKTCL-N usually presents multiple, generalized and
severe skin lesions, involving extremities and trunks
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area of the skin. The neoplastic cells infiltrated diffusely
in both dermis and subcutis, resulting in a column-like
low-power appearance and featured positive for CD56
and usually lack of T-cell receptor gene rearrangement
[9]. Furthermore, subcutaneous panniculitis-like T-cell
lymphoma (SPTCL) presents with deep subcutaneous
nodules rather than vesiculopapalar skin eruptions and
is invariably negative for EBV. In addition, primary
cutaneous gamma-delta T-cell lymphoma, which is now
included in primary cutaneous peripheral T-cell lymph-
oma, not otherwise specified is extremely rare and is also
negative for EBV.
With regard to the treatment of the tumor, Interferon-
α (IFN-α) is the most commonly selected whose major
side effects are fever and cytopenia. Corticosteroid is
usually used to control the symptoms, but it is not suit-
able to be used persistently. Chemotherapy is uncom-
monly used, because only 30% of patients may have
partial response. Xu reported six Chinese cases of child-
hood, in which, four patients received IFN-α, and two of
them also had chemotherapy (the regimen was un-
known) [8]. In current report, the patient was treated by
IFN-α and corticosteroid. Although the effect is not so
ideal, the progression is relatively slow. The prognosis-
related factor is unclear right now. According to the lim-
ited reports in the literature, the clinical course may be
indolent in patients with the NK-cell phenotype; whereas
cases with T-cell phenotype are characterized by inter-
mittent fever and hepatosplenomegaly. High titers of
EBV-related antibodies in the serum often predict a pro-
gressive clinical course and poor prognosis.
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